NET SALES OF PT ENSEVAL PUTERA MEGATRADING TBK GROWTH 4.8% AT THE END OF 2018
Jakarta, March 29, 2019 – Based on the Consolidated Financial Statements of PT Enseval Putera Megatrading Tbk and its Subsidiaries (“the Company”) on December 31, 2018 and for the year ending on that date (Audited), the Company informs that by the end of 2018, Sales Net of the Company was recorded at Rp20,604.49 billion or grew by 4.8% compared to Net Sales at the end of 2017 which was recorded at Rp19,669.10 billion. The Company’s Cost of Sales was recorded at Rp18,207.49 billion, growing by 3.8% compared to the Company’s Cost of Sales at the end of 2017 which was recorded at Rp17,534.91 billion. So that the Company can record Gross Profit of Rp2,397.00 billion, growing by 12.3% compared to Gross Profit at the end of 2017 which was recorded at Rp.2,134.19 billion.
At the end of 2018, the Company’s Operating Expenses were recorded at Rp1,568.90 billion, consisting of Sales Expenses of Rp1,362.20 billion and General and Administrative Expenses of Rp.206.70 billion, up 4.7% compared to the end of 2017 which was recorded at Rp1,498.26 billion. Therefore, the Company can record Operating Profit of Rp.828.10 billion.
From the comparison of the Company’s Consolidated Financial Position Report to December 31, 2018 (Audited) with the Company’s Consolidated Financial Position Report up to December 31, 2017 (Audited), the Company’s total assets increased from Rp7.43 trillion to Rp8.32 trillion or increased by 12.1%. The Company’s total liabilities increased by 10.5% from Rp.2.30 trillion to 31 December 2017 to Rp.2.54 trillion at the end of 2018. The Company’s total equity increased 12.8% from Rp5.13 trillion to Rp5.79 trillion.
Individual Performance – Each Division
The Company has 7 Divisions, which consist of the Division of Consumer Goods, Prescription Medicines, Free Medicines, Raw Materials for Sale, Health Equipment, Animal Medicine & Livestock and Health Services.
The details of the performance of each Division in the Company can be described as follows:
The Consumer Goods Division, is the division with the largest contribution to total Net Sales, which is 42.21%. At the end of 2018, this division managed to record Net Sales of Rp.8,698.00 billion or grew by 4.60% compared to 2017.
The Medical Prescription Division provided the second largest contribution after the Consumer Goods Division with a contribution of 27.68%. Until the end of 2018, the Prescription Medicines Division managed to record Net Sales of IDR 5,702.42 billion or grew by 2.55% compared to 2017.
The Free Medicines Division managed to record Net Sales of Rp3,032.82 billion at the end of 2018 with a contribution of 14.72% and an increase of 3.01% compared to 2017.
The Raw Materials Division for Sale recorded significant Net Sales of Rp1,748.38 billion at the end of 2018, growing by 18.04% compared to 2017. and contributed 8.49% to the Company’s Net Sales.
The Health Equipment Division contributed 6.70% at the end of 2018, with Net Sales recorded at Rp1,381.43 billion, an increase of 4.42% compared to 2017.
Net sales from the Animal and Animal Medicine Division were recorded at IDR 35.18 billion, down by 3.84% compared to 2017 which was recorded at IDR 36.59 billion. The Animal and Animal Medicine Division contributed 0.17% to the Company’s total Net Sales.
The Health Services Division contributed 0.03% of Net Sales recorded at IDR 6.25 billion, down by 21.21% compared to 2017.
Enseval is the largest Distribution Company in Indonesia which has started distribution activities since 1973 and has more than 4,500 employees. Enseval became an open company on August 1, 1994 under the name of PT Enseval Putera Megatrading Tbk (IDX: EPMT). In addition to distributing products from Kalbe Group, Enseval has also been trusted by principals – other principals both from within and outside the country. The Company has an extensive distribution network with 2 Regional Distribution Centers (RDC) located in Jakarta and Surabaya and 48 branches spread throughout the Indonesian Archipelago and 28 branches through the Subsidiary of PT Tri Sapta Jaya. Until now, the Company has 6 subsidiaries, which are engaged in distribution, raw materials, medical equipment and health services.
Jakarta, March 29, 2019
Changes in the composition of the Board of Commissioners, Audit Committee, Nomination & Remuneration Committee.
March 5, 2018
PT Enseval Putera Megatrading Tbk (the Company) with deep condolence, submitted the change of the composition of the Board of Commissioners, the Audit Committee, and the Nomination & Remuneration Committee in connection with the death of Mr. J.B. Apik Ibrahim as Independent Commissioner, Chairman of the Audit Committee and Chairman of the Company’s Nomination and Remuneration Committee on Thursday, March 1, 2018.Read More
NET SALES PT ENSEVAL PUTERA MEGATRADING TBK GROWTH BY 4.5% IN THE FIRST SEMESTER IN 2020
July 30, 2020
The Company’s Net Sales were recorded at Rp 11,501.78 billion or grew by 4.5% when compared to the Net Sales in the First Semester of 2019 which were recorded at Rp11,005.47 billion.Read More